Sage Therapeutics, Inc. (SAGE)
USD 5.03
(-4.55%)
USD 5.03
(-4.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 86.45 Million | 7.68 Million | 6.3 Million | 1.11 Billion | 6.86 Million | 90.27 Million |
| Cost of Revenue | 2.15 Million | 813 Thousand | 553 Thousand | 565 Thousand | 400 Thousand | 1.1 Million |
| Gross Profit | 84.29 Million | 6.87 Million | 5.75 Million | 1.11 Billion | 6.46 Million | 89.17 Million |
| Operating Expenses | 664.14 Million | 553.86 Million | 466.66 Million | 489.66 Million | 714.59 Million | 483.51 Million |
| Selling, General and Administrative Expenses | 274.52 Million | 227.69 Million | 183.49 Million | 196.95 Million | 345.77 Million | 201.4 Million |
| Research and Development Expenses | 356.23 Million | 326.16 Million | 283.16 Million | 292.71 Million | 368.81 Million | 282.1 Million |
| Other Expenses | 33.38 Million | 15 Thousand | 134 Thousand | 250 Thousand | 82 Thousand | 22 Thousand |
| Cost and Expenses | 666.3 Million | 554.67 Million | 467.21 Million | 490.23 Million | 714.99 Million | 483.51 Million |
| Operating Income | -579.84 Million | -546.98 Million | -460.9 Million | 596.22 Million | -708.12 Million | -393.23 Million |
| Interest Expense | - | 14.19 Million | - | - | - | - |
| Income Tax Expense | - | -29.51 Million | -7.06 Million | 15.51 Million | -30.08 Million | 20.35 Million |
| Earnings before Tax | -541.48 Million | -532.78 Million | -457.89 Million | 606.07 Million | -680.23 Million | -372.88 Million |
| Net Income | -541.48 Million | -503.26 Million | -450.82 Million | 606.07 Million | -650.15 Million | -372.88 Million |
| Earnings Per Share Basic | -9.05 | -8.49 | -7.68 | 11.66 | -12.79 | -8.08 |
| Earnings Per Share Diluted | -9.05 | -8.49 | -7.68 | 11.43 | -12.79 | -8.08 |
| Weighted Average Shares Outstanding | 59.83 Million | 59.3 Million | 58.67 Million | 51.98 Million | 50.83 Million | 46.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 59.83 Million | 59.3 Million | 58.67 Million | 53 Million | 50.83 Million | 46.12 Million |
| Gross Margin | 0.98 | 0.89 | 0.91 | 1.00 | 0.94 | 0.99 |
| EBIT Margin | -6.30 | -71.17 | -73.07 | 0.58 | -103.10 | -4.36 |
| Profit Margin | -6.26 | -65.48 | -71.47 | 0.54 | -94.66 | -4.13 |
| EBITDA | -545.07 Million | -545.86 Million | -456.72 Million | 626.59 Million | -705.84 Million | -392.09 Million |
| Earnings Before Tax Margin | -6.71 | -71.17 | -73.07 | 0.54 | -103.10 | -4.36 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 11.87 Million | 8.65 Million | 7.9 Million | 77.97 Million | 86.45 Million | 2.71 Million |
| Cost of Revenue | 5.27 Million | 1.4 Million | 1.26 Million | 820 Thousand | 2.15 Million | 905 Thousand |
| Gross Profit | 6.59 Million | 7.24 Million | 6.63 Million | 77.15 Million | 84.29 Million | 1.81 Million |
| Operating Expenses | 107.79 Million | 118.54 Million | 123.71 Million | 119.43 Million | 630.75 Million | 180.06 Million |
| Selling, General and Administrative Expenses | 53.21 Million | 55.98 Million | 51.97 Million | 55.1 Million | - | 78.14 Million |
| Research and Development Expenses | 54.57 Million | 62.56 Million | 71.73 Million | 64.33 Million | - | 101.91 Million |
| Other Expenses | - | 15 Thousand | -12 Thousand | -99 Thousand | -383 Thousand | -55 Thousand |
| Cost and Expenses | 113.07 Million | 119.95 Million | 124.98 Million | 120.25 Million | 632.91 Million | 180.96 Million |
| Operating Income | -101.2 Million | -111.3 Million | -117.07 Million | -42.07 Million | -579.84 Million | -211.84 Million |
| Interest Expense | - | - | - | 8.64 Million | - | - |
| Income Tax Expense | - | - | 292.72 Thousand | -9.68 Million | -5.35 Million | 23.32 Million |
| Earnings before Tax | -93.55 Million | -102.85 Million | -108.48 Million | -32.7 Million | -541.48 Million | -201.63 Million |
| Net Income | -93.55 Million | -102.85 Million | -108.48 Million | -32.7 Million | -541.48 Million | -201.63 Million |
| Earnings Per Share Basic | -1.53 | -1.70 | -1.80 | -0.55 | - | -3.37 |
| Earnings Per Share Diluted | -1.53 | -1.70 | -1.80 | -0.55 | - | -3.37 |
| Weighted Average Shares Outstanding | 61.11 Million | 60.53 Million | 60.13 Million | 59.99 Million | 59.83 Million | 59.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 61.11 Million | 60.53 Million | 60.13 Million | 59.99 Million | 59.83 Million | 59.91 Million |
| Gross Margin | 0.56 | 0.84 | 0.84 | 0.99 | 0.98 | 0.67 |
| EBIT Margin | -8.53 | -12.83 | -14.77 | -0.54 | - | -53.14 |
| Profit Margin | -7.88 | -11.89 | -13.73 | -0.42 | -6.26 | -74.24 |
| EBITDA | -101.2 Million | -110.98 Million | -116.74 Million | -42.09 Million | - | -144.32 Million |
| Earnings Before Tax Margin | -8.53 | -12.86 | -14.82 | -0.54 | -6.71 | -78.00 |
PVL
PSBKF
7508
0267
7490
IRDM